Nisa Investment Advisors
AVDL

Nisa Investment Advisors’s Avadel Pharmaceuticals AVDL Stock Holding History

Nisa Investment Advisors’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,165
Closed -$46.7K – 3047
2025
Q4 		$46.7K Sell
2,165
-1,139
-34% -$22.1K ﹤0.01% 1640
2025
Q3 		$50.5K Hold
3,304
– – ﹤0.01% 1630
2025
Q2 		$29.2K Buy
3,304
+2,055
+165% +$18.1K ﹤0.01% 1761
2025
Q1 		$9.78K Buy
1,249
+429
+52% +$3.59K ﹤0.01% 2098
2024
Q4 		$8.62K Sell
820
-228
-22% -$2.77K ﹤0.01% 2167
2024
Q3 		$13.7K Buy
1,048
+248
+31% +$3.78K ﹤0.01% 2026
2024
Q2 		$11.2K Buy
+800
New +$13K ﹤0.01% 2111

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Nisa Investment Advisors's AVDL Position: Q1 2026 in Review

Nisa Investment Advisors sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 2,165 shares — an estimated $46.7K sold.

Nisa Investment Advisors first reported a position in AVDL in Q2 2024 and held it in 7 quarters. The position peaked at $50.5K in Q3 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • Nisa Investment Advisors reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Nisa Investment Advisors sold 2,165 Avadel Pharmaceuticals shares in Q1 2026, an estimated $46.7K.
  • Nisa Investment Advisors first reported a position in Avadel Pharmaceuticals in Q2 2024 and held it in 7 quarters.
  • Nisa Investment Advisors's Avadel Pharmaceuticals position peaked at $50.5K in Q3 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.